Abstract Submission

The Abstract Deadline Is Over

Abstract Submission Deadlines

  • The deadline for abstract submission has been extended until September 4, 2024 (midnight)
  • Notification on acceptance/rejection: September 30, 2024

Rules for Submission

Please read the submission rules before submitting an abstract.

  • Abstracts must be submitted online via the website only. ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
  • Presentation Type: Abstracts may be submitted for oral or poster presentation. The posters will be displayed on boards during the Conference; the Committee will determine the date and location of the chosen posters. The Scientific Abstracts Committee will determine whether the abstract will be accepted for oral presentation, with consideration given to the author’s preference.
  • Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.

Limitations:

  • The same person may serve as presenting author on up to 5 abstracts.
  • Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees will be scheduled for presentation.
  • The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
  • Abstracts must be submitted in English. All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university specific publications office (or other similar facility) or by a copy editor, prior to submission.
  • Poster abstract should be presented in English.
  • Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.
  • Instructions for preparation of presentations will be made available on the conference website.

Guidlines for Submission

Before you begin, please prepare the following information:

  • Presenting author’s contact details:
    – Full first and family name(s)
    – Email address
    – Affiliation details: department, institution / hospital, city, state (if relevant), country
    – Phone number
  • Author and co-authors’ details
  • Preferred Presentation type: Oral/Poster presentation
  • Abstract title– must be in UPPER CASE and limited to 25 words. Please submit symbols as words
  • Abstract text– limited to 250 words including acknowledgements. Please note word count is affected when tables are included
  • Abstracts should clearly state:
    Background
    Methods
    Results
    Conclusions 
  • Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears 
  • Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content
  • Submissions may not contain patient names, hospital ID numbers or other identifying information.
  • Click on the SUBMIT button at the end of the process in order to submit your abstract
  • You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract
  • Please contact usif you have not received confirmation that your abstract has been submitted
  • Please do not submit multiple copies of the same abstract

Submit Your Abstract